The diverse pathology and kinetics of mass, nonmass, and focus enhancement on MR imaging of the breast

Purpose: To compare the pathology and kinetic characteristics of breast lesions with focus‐, mass‐, and nonmass‐like enhancement. Materials and Methods: A total of 852 MRI detected breast lesions in 697 patients were selected for an IRB approved review. Patients underwent dynamic contrast enhanced M...

Full description

Saved in:
Bibliographic Details
Published inJournal of magnetic resonance imaging Vol. 33; no. 6; pp. 1382 - 1389
Main Authors Jansen, Sanaz A., Shimauchi, Akiko, Zak, Lindsay, Fan, Xiaobing, Karczmar, Gregory S., Newstead, Gillian M.
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.06.2011
Subjects
Online AccessGet full text
ISSN1053-1807
1522-2586
1522-2586
DOI10.1002/jmri.22567

Cover

More Information
Summary:Purpose: To compare the pathology and kinetic characteristics of breast lesions with focus‐, mass‐, and nonmass‐like enhancement. Materials and Methods: A total of 852 MRI detected breast lesions in 697 patients were selected for an IRB approved review. Patients underwent dynamic contrast enhanced MRI using one pre‐ and three to six postcontrast T1‐weighted images. The “type” of enhancement was classified as mass, nonmass, or focus, and kinetic curves quantified by the initial enhancement percentage (E1), time to peak enhancement (Tpeak), and signal enhancement ratio (SER). These kinetic parameters were compared between malignant and benign lesions within each morphologic type. Results: A total of 552 lesions were classified as mass (396 malignant, 156 benign), 261 as nonmass (212 malignant, 49 benign), and 39 as focus (9 malignant, 30 benign). The most common pathology of malignant/benign lesions by morphology: for mass, invasive ductal carcinoma/fibroadenoma; for nonmass, ductal carcinoma in situ (DCIS)/fibrocystic change(FCC); for focus, DCIS/FCC. Benign mass lesions exhibited significantly lower E1, longer Tpeak, and lower SER compared with malignant mass lesions (P < 0.0001). Benign nonmass lesions exhibited only a lower SER compared with malignant nonmass lesions (P < 0.01). Conclusion: By considering the diverse pathology and kinetic characteristics of different lesion morphologies, diagnostic accuracy may be improved. J. Magn. Reson. Imaging 2011;33:1382–1389. © 2011 Wiley‐Liss, Inc.
Bibliography:ark:/67375/WNG-J8TVPWK1-9
ArticleID:JMRI22567
NIH - No. P50 CA125183-01 (SPORE)
Segal Foundation
Department of Defense - No. Predoctoral Award WX81XWH-06-1-0329
istex:5BCB352444D4C0AFC9A32A74861FBAA1266067EC
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Currently at Mouse Cancer Genetics Program, National Cancer Institute, Frederick Maryland
ISSN:1053-1807
1522-2586
1522-2586
DOI:10.1002/jmri.22567